Vapotherm (VAPO) Misses Q4 EPS by 8c

Go back to Vapotherm (VAPO) Misses Q4 EPS by 8c

Vapotherm Reports Fourth Quarter and Fiscal Year 2021 Financial Results

February 24, 2022 4:10 PM EST

2021 Revenue of $113.3 Million Reflects Two-Year Compounded Annual Growth Rate of 53%

Results in Line with Preliminary Revenue of $112.8 Million

Worldwide Installed Base of Precision Flow Hi-VNI® Systems Now 35,200

New Debt Facility Provides Up To $75 Million of Incremental Cash

EXETER, N.H.--(BUSINESS WIRE)-- Vapotherm, Inc. (NYSE: VAPO), (Vapotherm or the Company), a global medical technology company focused on the development and commercialization of its innovative, comfortable, non-invasive technologies for respiratory support of patients with chronic... More